Encorafenib Plus Cetuximab as a New Standard of Care for Previously Treated BRAF V600E-Mutant Metastatic Colorectal Cancer: Updated Survival Results and Subgroup Analyses from the BEACON Study

  1. Tabernero, J.
  2. Grothey, A.
  3. Van Cutsem, E.
  4. Yaeger, R.
  5. Wasan, H.
  6. Yoshino, T.
  7. Desai, J.
  8. Ciardiello, F.
  9. Loupakis, F.
  10. Hong, Y.S.
  11. Steeghs, N.
  12. Guren, T.K.
  13. Arkenau, H.-T.
  14. Garcia-Alfonso, P.
  15. Elez, E.
  16. Gollerkeri, A.
  17. Maharry, K.
  18. Christy-Bittel, J.
  19. Kopetz, S.
Revista:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology

ISSN: 1527-7755

Any de publicació: 2021

Volum: 39

Número: 4

Pàgines: 273-284

Tipus: Article

DOI: 10.1200/JCO.20.02088 GOOGLE SCHOLAR lock_openAccés obert editor

Objectius de Desenvolupament Sostenible

Font de les dades: Scopus